| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/18/2006 | EP1392309A4 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/18/2006 | EP1292590B1 Admantane derivatives |
| 01/18/2006 | EP1268096B1 Extrusion die |
| 01/18/2006 | EP1220852B1 Substituted diazepans |
| 01/18/2006 | EP1214064A4 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 01/18/2006 | EP1210327B1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 01/18/2006 | EP1200320B9 Valve with a two-component seal |
| 01/18/2006 | CN1723480A System and method for transparent early detection, warning, and intervention during a medical procedure |
| 01/18/2006 | CN1723210A Fused furan compound |
| 01/18/2006 | CN1723201A Blood-brain barrier disruption inhibitors |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof |
| 01/18/2006 | CN1721447A Modified peptides as therapeutic agents |
| 01/18/2006 | CN1721431A Novel alpha-melanocyte stimulating hormone analogue and use thereof |
| 01/18/2006 | CN1721412A 7-oxo pyridopyrimidines |
| 01/18/2006 | CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof |
| 01/18/2006 | CN1720999A Hab18G/CD147 molecule small segment interfering RNA medicine and application thereof |
| 01/18/2006 | CN1720991A Degraded agonist antibody |
| 01/18/2006 | CN1720985A Erythromelalgia treating medicine |
| 01/18/2006 | CN1720973A Compound drop pills of stramonium and its preparation method |
| 01/18/2006 | CN1720967A Inflammation-resisting pain-stopping preparation |
| 01/18/2006 | CN1720961A Medicinal incense for dispelling wind-dampness and method for manufacturing the same |
| 01/18/2006 | CN1720953A Method for preparing gene-caring weight-reducing medicine |
| 01/18/2006 | CN1720950A Compound drop pills of Chinese angelica and its preparation method |
| 01/18/2006 | CN1720948A Dripping pills of lllicium henryi dripping pills and method for preparing the same |
| 01/18/2006 | CN1720947A Dripping pills with mistletoe and Chinese angelica root and process for preparing the same |
| 01/18/2006 | CN1720946A Bone strengthening dripping pills with Premena fulva craib as raw material and method for preparing the same |
| 01/18/2006 | CN1720939A Instant pain-stopping medicament |
| 01/18/2006 | CN1720938A Medicine for treating rheumatic arthritis and ankylosing spondylitis and its preparing process |
| 01/18/2006 | CN1720937A Capsule for treating rheumatism and rheumatoid diseases and scapulohumeral periarthritis and preparation method thereof |
| 01/18/2006 | CN1720933A Tendon and bone strengthening capsule |
| 01/18/2006 | CN1720929A Fresh centipede region divided extract and extraction method |
| 01/18/2006 | CN1237176C Method for remodelling cell wall polysaccharide structures in plants |
| 01/18/2006 | CN1237075C Low molecular weight peptide derivatives as inhibitors of laminin/nidogen interaction |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/18/2006 | CN1237061C Chemokine receptor binding heterocyclic compounds |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/18/2006 | CN1236803C Rheuamtism treating Chinese medicine |
| 01/18/2006 | CN1236793C Medicinal formula for treating sciatic nerve disease and protrusion of lumbar intervertebral disc |
| 01/18/2006 | CN1236792C Brain active effect matter for prevention and treating encephalopathy and developing intelligence and its preparation method |
| 01/18/2006 | CN1236786C Ointment with functions of detoxification, relieving inflammation and stopping pain |
| 01/18/2006 | CN1236774C Highly concentrated stable meloxicam solutions |
| 01/18/2006 | CN1236773C Preparation for analgesia and anesthesia or treating drug dependence |
| 01/18/2006 | CN1236769C Inhibitor for inhibiting cell adhesion |
| 01/18/2006 | CN1236767C Vitronectin receptor antagonists |
| 01/17/2006 | US6987184 Isothiazoloanthrones, isoxazoloanthrones, isoindolanthrones and derivatives thereof as JNK inhibitors and compositions and methods related |
| 01/17/2006 | US6987168 Tryptase inhibitor proteins derived from blood-feeding anthropod ectoparasites |
| 01/17/2006 | US6987128 Compounds of the N-acylamino amide family, compositions comprising same, and uses |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6987092 Indigoid bisindole derivatives |
| 01/17/2006 | US6987088 Novel compounds which bind to the human erbB2 gene product (ErbB2, also known as HER2, or c-ErbB-2). In particular aspects, the invention provides for the treatment of disorders characterized by the overexpression of ErbB2 utilizing the |
| 01/17/2006 | US6986996 Using anti-heparanase antibody to bind heparanase encoded by amino acid sequence no.1 for monitoring heparanase protein expression of heparanase gene in white blood cells in vitro; drug delivery targets; diagnosis of tumors, cancer and metastasis |
| 01/17/2006 | CA2334713C Therapeutic biaryl derivatives |
| 01/17/2006 | CA2177171C Novel substituted oxazolidines |
| 01/12/2006 | WO2006003495A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 01/12/2006 | US20060009513 Nebivolol and its metabolites in combination with nitric oxide donors, compositions and methods of use |
| 01/12/2006 | US20060009495 Diary 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/12/2006 | US20060009494 Compositions and methods for use against acne-induced inflammation and dermal matrix-degrading enzymes |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009439 Novel physiologically active substances |
| 01/12/2006 | US20060009412 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060009403 Dna demethylase antisense and chemotherapy combination |
| 01/12/2006 | US20060008802 Method for the identification of inhibitors of the binding of are-containing mrna and a hur protein |
| 01/12/2006 | US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation |
| 01/12/2006 | US20060008574 Galactosyl isomalt, method for production and use thereof |
| 01/12/2006 | US20060008542 Preparation containing a mixture of picrorrhiza and ginkgo for the relief of disease |
| 01/12/2006 | US20060008471 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus |
| 01/12/2006 | DE202005017669U1 Antimicrobial agent, useful to treat respiratory tract related microorganisms or infectious diseases in nose-, throat- or paranasal sinuses, comprises plant drug or ethanolic/aqueous extracts (e.g. Rumex acetosa L) |
| 01/12/2006 | DE19961182B4 Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung Galactomannan oligosaccharides and processes for their preparation and their use |
| 01/12/2006 | CA2573193A1 Substituted heteroaryl- and phenylsulfamoyl compounds |
| 01/12/2006 | CA2572321A1 Anti-synoviolin antibody |
| 01/12/2006 | CA2572316A1 Imidazolo-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572163A1 Pyrazole derivatives |
| 01/12/2006 | CA2572118A1 Method for preparing 5-`4-(2-hydroxy-ethyl)-3,5-dioxo-4,5-dihydro-3h-`1,2,4!-triazin-2-yl!benzamide derivatives with p2x7 inhibiting activity by reaction of the derivative unsubstituted in 4-position of the triazine with an oxiran in the presence of a lewis acid |
| 01/12/2006 | CA2572084A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572083A1 Fused pyrimidine derivatives and compositions thereof as cxcr3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 01/12/2006 | CA2572075A1 Hetero isonipecotic modulators of vanilloid vr1 receptor |
| 01/12/2006 | CA2571588A1 Pyrazolopyridine derivatives |
| 01/12/2006 | CA2570318A1 Biaryl derivatives |
| 01/12/2006 | CA2570213A1 Alpha-helical mimetics |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/11/2006 | EP1614697A1 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614675A2 Amino acids with affinity for the alpha-2-delta protein |
| 01/11/2006 | EP1614432A2 Method for treating amyloidosis |
| 01/11/2006 | EP1614421A2 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/11/2006 | EP1613616A2 Process for making substituted pyrazoles |
| 01/11/2006 | EP1613595A2 Novel compounds and compositions as protein kinase inhibitors |
| 01/11/2006 | EP1613588A2 2-propylidene-19-nor-vitamin d compounds |
| 01/11/2006 | EP1613336A1 Histamine binding compounds for treatment method for disease conditions mediated by neutrophils |
| 01/11/2006 | EP1613332A2 Formulations for mediating inflammation and for reducing blood cholesterol |
| 01/11/2006 | EP1613321A2 Muscarinic m1 receptor agonists for pain management |